genedrive plc announces multi-tiered shares sale
MANCHESTER, UK: genedrive plc (LSE: GDR), a leader in point-of-care pharmacogenetic testing, has unveiled a comprehensive fundraising initiative aimed at securing approximately £8.1 million. The strategy includes a placing of shares at 1.5 pence each, significantly below the closing price on 8 May 2024, with no underwriting involved. The fundraising is structured into three main…